UNIVERSITY OF ARIZONA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.arizona.edu
Traditional Chinese Medicine (TCM) for Temporomandibular Dysfunction (TMD): A Whole Systems Multi-site Trial
Phase 2
Completed
- Conditions
- Temporomandibular Dysfunction
- Interventions
- Behavioral: Self-care for TMDDrug: TCM
- First Posted Date
- 2009-03-05
- Last Posted Date
- 2015-05-27
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 160
- Registration Number
- NCT00856167
Sleep and Glucose Regulation in Youth With Type 1 Diabetes Mellitus
Completed
- Conditions
- SleepType 1 Diabetes Mellitus
- First Posted Date
- 2009-02-20
- Last Posted Date
- 2011-04-15
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 50
- Registration Number
- NCT00848822
- Locations
- 🇺🇸
Steele Research Memorial Foundation, Angel Clinic for Children with Diabetes and Endocrine Disorders, Tucson, Arizona, United States
Safety and PK of Nikkomycin Z in Healthy Subjects
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2020-11-23
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 32
- Registration Number
- NCT00834184
- Locations
- 🇺🇸
Clinical & Translational Research Center - University of Arizona, Tucson, Arizona, United States
Influenza Vaccination in the Emergency Department
Not Applicable
Completed
- Conditions
- Influenza
- Interventions
- Drug: Influenza VaccinationBehavioral: Education and referral
- First Posted Date
- 2009-01-14
- Last Posted Date
- 2009-01-14
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 140
- Registration Number
- NCT00822627
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome
Phase 4
Completed
- Conditions
- Sleep DisorderAcute Coronary Syndrome
- Interventions
- Other: Placebo
- First Posted Date
- 2009-01-14
- Last Posted Date
- 2016-12-20
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 5
- Registration Number
- NCT00822679
- Locations
- 🇺🇸
Southern Arizona VA Health Care System, Tucson, Arizona, United States
Telephone Counseling: Men With Prostate Cancer & Partners
Phase 1
Completed
- Conditions
- Prostate Cancer
- Interventions
- Behavioral: Telephone Interpersonal CounselingBehavioral: Telephone delivered education only
- First Posted Date
- 2009-01-14
- Last Posted Date
- 2018-05-11
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 79
- Registration Number
- NCT00822510
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis
Completed
- Conditions
- CoccidioidomycosisRheumatoid Arthritis
- First Posted Date
- 2008-11-24
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 598
- Registration Number
- NCT00796809
- Locations
- 🇺🇸
University of Arizona - Arizona Arthritis Center, Tucson, Arizona, United States
Selenium in Treating Patients With Prostate Cancer
Phase 2
Completed
- Conditions
- Prostate Cancer
- Interventions
- Other: placeboDietary Supplement: selenium
- First Posted Date
- 2008-09-15
- Last Posted Date
- 2012-08-15
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 220
- Registration Number
- NCT00752739
- Locations
- 🇺🇸
Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States
Diagnosis of Exercise-induced Bronchospasm (EIB) and Asthma in National Collegiate Athletic Association (NCAA) Division I Athletes
Completed
- Conditions
- Exercise Induced Bronchospasm, Asthma
- First Posted Date
- 2008-09-15
- Last Posted Date
- 2016-05-12
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 74
- Registration Number
- NCT00752167
- Locations
- 🇺🇸
University of Arizona, Tucson, Arizona, United States
Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL
Phase 2
Completed
- Conditions
- Lymphoma
- Interventions
- Drug: In-ZevalinDrug: Y-Zevalin
- First Posted Date
- 2008-08-12
- Last Posted Date
- 2019-09-04
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 28
- Registration Number
- NCT00732498
- Locations
- 🇺🇸
The University of Arizona Cancer Center, Tucson, Arizona, United States
© Copyright 2025. All Rights Reserved by MedPath